Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in DENALI THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 5M shares of DNLI (DENALI THERAPEUTICS INC), worth $82.3M as of 2025-Q4. The position was decreased (-8.8% shares). DNLI represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$82.3M
Current Shares
5M
Total Value Change
+$28.9M
Total Shares Change
+2.7M
Other major holders of DNLI: BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A., BAILLIE GIFFORD & CO
Decreased |
| 5M |
-8.8% |
| $82.3M |
| 0.0% |
| $16.41 |
0 |
| 2025-Q3 | Decreased | 5.5M | -12.7% | $79.4M | 0.0% | $14.52 | 0 |
| 2025-Q2 | Decreased | 6.3M | -7.5% | $87.6M | 0.0% | $14.10 | 0 |
| 2025-Q1 | Increased | 6.8M | +88.9% | $92M | 0.0% | $14.78 | 47 |
| 2024-Q4 | Decreased | 3.6M | -4.4% | $73M | 0.0% | $20.24 | 0 |
| 2024-Q3 | Increased | 3.7M | +63.2% | $109.2M | 0.0% | $29.43 | 44 |
| 2024-Q2 | Increased | 2.3M | +234.3% | $53.4M | 0.0% | $23.22 | 47 |